| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/19/2008 | CA2671980A1 Quinoxaline derivatives |
| 06/19/2008 | CA2671863A1 Method of treating acute renal failure with thrombomodulin variants |
| 06/18/2008 | EP1931797A2 Pde inhibitors and combinations thereof for the treatment of urological disorders |
| 06/18/2008 | EP1931689A2 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
| 06/18/2008 | EP1931631A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 06/18/2008 | EP1931199A2 Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators |
| 06/18/2008 | EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 06/18/2008 | EP1106176B1 Remedies for renal failure |
| 06/18/2008 | CN101203217A Methods for modulating bladder function |
| 06/18/2008 | CN101199848A Drug compound for Ca channel retarder/diuretic/ folate coupling and function |
| 06/18/2008 | CN101199847A Drug compound for AT1 receptor antagonist/diuretic/folate coupling and uses thereof |
| 06/18/2008 | CN101199818A Medicament compound for treating calculus |
| 06/18/2008 | CN101199816A Medicament for prostate disease |
| 06/18/2008 | CN101199804A Powders medicament for treating wean enuresis |
| 06/18/2008 | CN101199803A Oral administration Chinese medicine for treating wean enuresis |
| 06/18/2008 | CN101199800A Tonifythekidney aphrodisiac external medicament package |
| 06/18/2008 | CN101199730A Extracting technique of garlic glucoside and garlic biological activity component compound and function |
| 06/18/2008 | CN101199722A Chinese medicine compound for oral administration for treating chronicity nephritis |
| 06/18/2008 | CN101199720A Chinese medicine compound for oral administration for treating chronicity nephritis |
| 06/18/2008 | CN101199719A Intensity kidney particle producing process |
| 06/18/2008 | CN101199718A Female protected kidney capsule |
| 06/18/2008 | CN101199716A Active male capsule and preparing method thereof |
| 06/18/2008 | CN101199715A Male-protecting kidney capsule and preparing method thereof |
| 06/18/2008 | CN101199698A Wine of six ingredients with rehmannia and preparing method thereof |
| 06/18/2008 | CN101199697A Nourishing kidney expellant medicament |
| 06/18/2008 | CN101199687A Medicament compound for treating chronic prostatitis and preparing method thereof |
| 06/18/2008 | CN101199671A Oral administration Chinese medicine for treating habits weak wean enuresis |
| 06/18/2008 | CN101199625A Pediluvium medicament for treating wean enuresis |
| 06/18/2008 | CN101199574A Function of extract of boraginaceae cynoglossum furcatum class plant in preparing anti-inflammation analgesis medicament |
| 06/18/2008 | CN101199534A Anti-tumor function of raw panoxadiol derivative |
| 06/18/2008 | CN101199486A Ratio karoo amine slice and preparing technique thereof |
| 06/18/2008 | CN100394978C Chinese medicine for treating urinaemia |
| 06/18/2008 | CN100394967C Chinese medicine composition for treating wrinary tract disease |
| 06/18/2008 | CN100394939C Pure Chinese medicine oral preparation for treating prostate disease and its preparation metod |
| 06/17/2008 | US7388086 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7387776 Human monoclonal antibodies against CD30 |
| 06/17/2008 | CA2444053C Fused bicyclic or tricyclic amino acids |
| 06/17/2008 | CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 06/17/2008 | CA2393749C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 06/17/2008 | CA2367704C Pyrazolobenzodiazepines as cdk2 inhibitors |
| 06/17/2008 | CA2188892C Use of an yttrium salt in a compound for the treatment of sensitive skin |
| 06/12/2008 | WO2008070778A2 Pyridoxamine and low molecular weight heparinoids for diabetic kidney disease |
| 06/12/2008 | WO2008070117A1 Conjoint therapy for treating fibrotic diseases |
| 06/12/2008 | WO2008069242A1 Novel bicyclic heterocyclic compound |
| 06/12/2008 | WO2008042688A3 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| 06/12/2008 | US20080140138 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 06/12/2008 | US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 06/12/2008 | US20080139664 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| 06/12/2008 | US20080139636 Adamantane derivatives |
| 06/12/2008 | US20080138421 And a stabilizer of xylitol, sorbitol, polydextrose, isomalt, dextrose; gel matrix; urinary incontinence, urinary urge incontinence, imperative urinary urge, and/or increased urinary frequency |
| 06/12/2008 | US20080138345 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/12/2008 | CA2708004A1 Conjoint therapy for treating fibrotic diseases |
| 06/11/2008 | EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain |
| 06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
| 06/11/2008 | EP1930023A2 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 06/11/2008 | EP1930022A1 Treatment of bladder fibrosis with antibodies against alpha V beta 6 integrin |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1930000A1 Combination of organic compounds |
| 06/11/2008 | EP1928885A1 Fused tricyclic (mglur1) antagonists as therapeutic agents |
| 06/11/2008 | EP1928551A2 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals |
| 06/11/2008 | EP1928483A1 Factor h for the treatment of chronic nephropathies and production thereof |
| 06/11/2008 | EP1928463A2 Method of using potassium channel inhibiting compounds |
| 06/11/2008 | EP1928454A2 Pyridone derivatives for modulating stress-activated protein kinase system |
| 06/11/2008 | EP1928453A2 Methods and compositions for the preventioin and treatment of kidney disease |
| 06/11/2008 | EP1928349A2 Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
| 06/11/2008 | EP1638933B1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 06/11/2008 | EP1444235B1 Reverse-turn mimetics and method relating thereto |
| 06/11/2008 | EP1165113B1 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 06/11/2008 | CN101198614A Thienopyrimidine derivative |
| 06/11/2008 | CN101198582A Polymorphic crystal of 4'-{2-[ (1s, 2r) - 2- hydroxy -2- (4-hydroxyphenyl) -1- methylethylamino] ethoxy} - 3 - isopropyl-3', 5' -dimethylbiphenyl - 4 - carboxylic acid hydrochloride |
| 06/11/2008 | CN101198321A Hematopoietic factor production promoter |
| 06/11/2008 | CN101195011A Chinese medicine for treating prostatitis and hyperplasia |
| 06/11/2008 | CN101194993A Umbilicus applying medicament for treating children's nocturia |
| 06/11/2008 | CN101194991A Air making-up and spleen enlivening Chinese medicine |
| 06/11/2008 | CN101194984A Chinese medicine composition for treating early and medium-term chronic renal failure |
| 06/11/2008 | CN101194948A Orally taken Chinese medicine composition for treating cystitis |
| 06/11/2008 | CN101194656A Method of preparing matrimony vine tea |
| 06/11/2008 | CN100393716C Coumarin derivatives, and their preparing method and use as alpha, receptor agonist |
| 06/11/2008 | CN100393339C Kidney-tonifying brain-invigorating medicine and preparation process thereof |
| 06/11/2008 | CN100393316C Suppository containing prazosin hydrochloride, its preparation method and application |
| 06/10/2008 | US7385083 Calcium-activated potassium channel (BK channel) with opening activity equivalent to or higher than that of maxikdiol, and has high specificity |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7384983 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders |
| 06/10/2008 | US7384980 Derivatives of 3,3-diphenylpropylamines |
| 06/10/2008 | US7384976 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 06/10/2008 | US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase |
| 06/10/2008 | US7384960 Cannabinoid CB1 receptor antagonists; e.g. substituted 1,5-dihydroisothiochromeno[4,3-c]pyrazole-3-carboxamide compounds; schizophrenia, memory, appetite disorders |
| 06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384943 Substituted chroman derivatives |
| 06/10/2008 | CA2310028C High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 06/10/2008 | CA2129046C Opioid diarylmethylpiperazines and piperidines |
| 06/05/2008 | WO2008066298A1 Compound for treatment or prevention of prostate-related diseases and pharmaceutical composition of colon delivery system containing the same |
| 06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 06/05/2008 | WO2008066117A1 Cyclic amine compound |
| 06/05/2008 | WO2008066064A1 Regulation of the activity of transcriptional factor stat by zinc ion |
| 06/05/2008 | WO2008065754A1 Substituted carbinol compound |
| 06/05/2008 | WO2008064595A1 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide |